Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study

• Sergio Matarraz,
• Pilar Leoz,
• Ana Yeguas-Bermejo,
• Vincent van der Velden,
• Anne E. Bras,
• Jose I. Sánchez Gallego,
• Quentin Lecrevisse,
• Rosa Ayala-Bueno,
• Cristina Teodosio,
• Ignacio Criado,
• María González-González,
• Juan Flores-Montero,
• Alejandro Avendaño,
• María B. Vidriales,
• María C. Chillón,
• Teresa González,
• Ramón García-Sanz,
• María I. Prieto Conde,
• Neus Villamor,
• Laura Magnano,
• Enrique Colado,
• Paula Fernández,
• Edwin Sonneveld,
• Jan Philippé,
• Michaela Reiterová,
• Juan C. Caballero Berrocal,
• Francisco J. Diaz-Gálvez,
• Fernando Ramos,
• Julio Dávila Valls,
• Raquel Manjón Sánchez,
• Jackeline Solano Tovar,
• Xavier Calvo,
• Luis García Alonso,
• Leonor Arenillas,
• Sara Alonso,
• Ariana Fonseca,
• Covadonga Quirós Caso,
• Jacques J. M. van Dongen,
• Alberto Orfao

Affiliations

Sergio Matarraz

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Pilar Leoz

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Ana Yeguas-Bermejo

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Vincent van der Velden

Department of Immunology, Erasmus MC, University Medical Center Rotterdam

Anne E. Bras

Department of Immunology, Erasmus MC, University Medical Center Rotterdam

Jose I. Sánchez Gallego

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Quentin Lecrevisse

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Rosa Ayala-Bueno

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Cristina Teodosio

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Ignacio Criado

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

María González-González

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Juan Flores-Montero

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Alejandro Avendaño

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

María B. Vidriales

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

María C. Chillón

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Teresa González

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Ramón García-Sanz

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

María I. Prieto Conde

Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III

Neus Villamor

Hematology Service, Hospital Clinic

Laura Magnano

Hematology Service, Hospital Clinic

Enrique Colado

Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias

Paula Fernández

FACS/Stem Cell Laboratory, Kantonsspital Aarau

Edwin Sonneveld

Dutch Childhood Oncology Group

Jan Philippé

Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University

Michaela Reiterová

CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol

Juan C. Caballero Berrocal

Department of Hematology, Hospital Clínico Universitario de Valladolid

Francisco J. Diaz-Gálvez

Department of Hematology, Hospital Universitario de Burgos

Fernando Ramos

Department of Hematology, Complejo Asistencial Universitario de León

Julio Dávila Valls

Department of Hematology, Complejo Asistencial de Ávila

Raquel Manjón Sánchez

Department of Hematology, Complejo Asistencial de Zamora

Jackeline Solano Tovar

Department of Hematology, Complejo Asistencial Universitario de Palencia

Xavier Calvo

Pathology Service, Hospital del Mar

Luis García Alonso

Hematology Service, University Hospital of Getafe

Leonor Arenillas

Pathology Service, Hospital del Mar

Sara Alonso

Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias

Ariana Fonseca

Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias

Covadonga Quirós Caso

Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias

Jacques J. M. van Dongen

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)

Alberto Orfao

Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL)